InvestorsHub Logo

vg_future

02/12/21 9:46 AM

#298533 RE: boi568 #298529

boi568, just to be clear, Dr. M's comment was specifically for the RETT trial participants. Some on this board have a tendency to take this out of context and apply it to the ALZ related SAS NEWS from last year. Anavex (and in fact the official folks in Australia) have made it clear that that approval is open to any of the patients if their doctor can apply for or request the use.

-vg_future

XenaLives

02/12/21 9:51 AM

#298537 RE: boi568 #298529

This is not clear - but if Anavex was expecting P4 for Alzheimer's it might be wise not to encourage Special Access at this time.

We really don't know what we don't know.